These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1458883)

  • 41. Health-care reform and antitrust. A primer for physicians.
    Harty-Golder B; Garland RR
    J Fla Med Assoc; 1993 May; 80(5):351-4. PubMed ID: 8315410
    [No Abstract]   [Full Text] [Related]  

  • 42. Industry consolidation means fewer competitors for health plans.
    Med Health; 2006 Jun; 60(21):1, 5. PubMed ID: 16764354
    [No Abstract]   [Full Text] [Related]  

  • 43. Washington turns up antitrust heat on doctors.
    Slomski AJ
    Med Econ; 1991 Aug; 68(15):42-8. PubMed ID: 10112155
    [No Abstract]   [Full Text] [Related]  

  • 44. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managed competition: implications for radiology.
    Straub WH
    Radiology; 1993 Aug; 188(2):51A-55A. PubMed ID: 8327706
    [No Abstract]   [Full Text] [Related]  

  • 46. Competitors share contracts.
    Lovern E
    Mod Healthc; 2001 Jan; 31(3):4-5, 10. PubMed ID: 11418946
    [No Abstract]   [Full Text] [Related]  

  • 47. Powerful networks could result in public utility-style regulation of health care.
    Weil TP
    Healthspan; 1995 Feb; 12(2):12-5. PubMed ID: 10166119
    [No Abstract]   [Full Text] [Related]  

  • 48. Antitrust reform from the physicians' perspective.
    Berg RN
    J Med Assoc Ga; 1994 Dec; 83(12):705-10. PubMed ID: 7822960
    [No Abstract]   [Full Text] [Related]  

  • 49. Can HMOs wield market power? Assessing antitrust liability in the imperfect market for health care financing.
    Glassman ML
    Am Univ Law Rev; 1996 Oct; 46(1):91-147. PubMed ID: 10169685
    [No Abstract]   [Full Text] [Related]  

  • 50. Most Favored Nation clauses require close scrutiny.
    Roeder KH
    Ga Hosp Today; 1995 Nov; 39(11):3. PubMed ID: 10152770
    [No Abstract]   [Full Text] [Related]  

  • 51. Judge Posner's RFP: antitrust law and managed care.
    Sage WM
    Health Aff (Millwood); 1997; 16(6):44-61. PubMed ID: 9444808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health maintenance organizations and the specter of antitrust law.
    Ferrari BT; Sponsler TH
    Spec Law Dig Health Care (Mon); 1988 Jan; 9(7):7-34. PubMed ID: 10285562
    [No Abstract]   [Full Text] [Related]  

  • 53. Hospital-physician collaboration and competition: the antitrust connection.
    Enders RJ
    Healthc Financ Manage; 1986 Apr; 40(4):60-8. PubMed ID: 10275461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Legal considerations for periodontists in dealing with managed care organizations.
    Bierig JR
    J Periodontol; 1998 Feb; 69(2):254-60. PubMed ID: 9526925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increasing consolidation in healthcare markets: what are the antitrust policy implications?
    Haas-Wilson D; Gaynor M
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1403-19. PubMed ID: 9865226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital markets and competition: implications for antitrust policy.
    Nguyen NX; Derrick FW
    Health Care Manage Rev; 1994; 19(1):34-43. PubMed ID: 8206760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What if your hospital corners the medical market?
    Terry K
    Med Econ; 1996 Feb; 73(4):138-9, 144-6, 148-50. PubMed ID: 10172574
    [No Abstract]   [Full Text] [Related]  

  • 58. Physician practice integration and consolidation: an antitrust enforcement perspective.
    Wessler SL
    Int Ophthalmol Clin; 1998; 38(3):45-57. PubMed ID: 9742432
    [No Abstract]   [Full Text] [Related]  

  • 59. New sheriff in town. Health insurers take antitrust enforcement matters into own hands with litany of lawsuits.
    Taylor M
    Mod Healthc; 2001 Dec; 31(49):26-8. PubMed ID: 11765364
    [No Abstract]   [Full Text] [Related]  

  • 60. Let's take on the real dragon: profiteering in health care.
    Braveman P; Bennett T
    J Public Health Policy; 1995; 16(3):261-8. PubMed ID: 7499510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.